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Abstract. 60 
 61 
Mucosal-associated invariant T (MAIT) cells typically express a TRAV1-2+ semi-invariant 62 
TCR that enables recognition of bacterial, mycobacterial, and fungal riboflavin 63 
metabolites presented by MR1. MAIT cells are associated with immune control of 64 
bacterial and mycobacterial infections in murine models. Here, we report that a 65 
population of pro-inflammatory TRAV1-2+ CD8+ T cells are present in the airways and 66 
lungs of healthy individuals and are enriched in bronchoalveolar fluid of patients with 67 
active pulmonary tuberculosis (TB). High-throughput T cell receptor analysis reveals 68 
oligoclonal expansions of canonical and donor-unique TRAV1-2+ MAIT-consistent TCR 69 
sequences within this population.  Some of these cells demonstrate MR1-restricted 70 
mycobacterial reactivity and phenotypes suggestive of MAIT cell identity. These findings 71 
demonstrate enrichment of TRAV1-2+ CD8+ T cells with MAIT or MAIT-like features in 72 
the airways during active TB and suggest a role for these cells in the human pulmonary 73 
immune response to Mycobacterium tuberculosis. 74 
 75 
Introduction 76 
 77 
Mucosal-associated invariant T (MAIT) cells are unconventional lymphocytes that use 78 
semi-invariant T cell receptor-alpha (TCR) chains to recognize non-peptide small 79 
molecule ligands presented by the HLA-Ib molecule MR11-6. In mice, MAIT cells have 80 
been shown to play a protective role in models of respiratory infection 7-10. In humans, 81 
MAIT cells are abundant in the peripheral blood of healthy individuals, where they 82 
produce cytolytic enzymes and pro-inflammatory cytokines and typically express a 83 
TRAV1-2+ TCR chain and the CD8 coreceptor1-4,11-13. MAIT cells are depleted in the 84 
blood of humans with TB4,5,14. However, little is known about the function and phenotype 85 
of MAIT cells in the human lung, especially in the setting of pulmonary tuberculosis (TB). 86 
We postulated that MAIT cells are recruited to and/or expand at sites where 87 
Mycobacterium tuberculosis (Mtb) antigens are present, potentially acting as sentinels of 88 
infection in the respiratory mucosa. 89 
 90 
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Here we report that a population of pro-inflammatory TRAV1-2+ CD8+ T cells are present 91 
in the airways and lungs of healthy individuals and are enriched in bronchoalveolar fluid 92 
of patients with active pulmonary TB. Some of these cells demonstrate MR1-restricted 93 
mycobacterial reactivity, phenotypic features and/or TCR chain usage suggestive of 94 
MAIT cell identity. We conclude that TRAV1-2+ CD8+ T cells with MAIT or MAIT-like 95 
features are oligoclonally expanded in the airways during active TB suggesting that they 96 
play a role in the human pulmonary immune response to Mycobacterium tuberculosis. 97 
 98 
Results  99 
TRAV1-2+ CD8+ T cells in human lung and intestine tissues 100 
To explore the role of MAIT cells in healthy mucosal tissues, we first determined the 101 
frequency of TRAV1-2+ CD8+ cells in the respiratory tract of an individual organ donor 102 
(Fig. 1a). Dramatic enrichment was observed in the trachea, where nearly half of all 103 
CD8+ T cells expressed TRAV1-2 (Fig. 1a). TRAV1-2+ cells were also enriched in the 104 
proximal and distal bronchi (35% and 22% of CD8+ T cells respectively) and in the lung 105 
parenchyma (17% of CD8+ T cells), relative to the draining mediastinal lymph node 106 
where the frequency (6% of CD8+ T cells) approximated levels typically found in 107 
peripheral blood11,15. To determine the anatomical localization of TRAV1-2+ CD8+ cells in 108 
the airway, we used immunohistochemistry to quantify CD8+ and TRAV1-2+ cells in 1st 109 
and 2nd order bronchial sections from three additional organ donors (Fig. 1b, left).  110 
Although the number of CD8+ cells was similar in tissue sections from the proximal and 111 
distal airways, TRAV1-2+ cells were more frequent in the proximal compared to distal 112 
airway (Fig. 1b, right). As expression of TRAV1-2+ TCRs is insufficient to define MAIT 113 
cells, we also performed ex vivo functional assays in which cytokine-production by 114 
TRAV1-2+ CD8+ cells upon exposure to HLA mis-matched M. smegmatis-infected 115 
antigen-presenting cells is used to define mycobacterial-reactive MAIT cells4,12,16,17. In a 116 
single donor for whom paired tissues were available, we evaluated lymphocytes from 117 
lung parenchyma, the small intestinal lamina propria (LP), and the small intestinal 118 
intraepithelial lymphocytes (IEL) for M. smegmatis-dependent release of the pro-119 
inflammatory cytokine TNF. Interestingly, TNF-producing TRAV1-2+ cells were found 120 
only in the lung (Fig.1c, left). It is also notable that CD161, a C-type lectin highly 121 
expressed on peripheral MAIT cells11,13,17, was not detected on TRAV1-2+ CD8+ T cells 122 
from the lung but was found in abundance on small intestinal TRAV1-2+ CD8+ T cells 123 
(Fig.1c, right). We next compared the frequencies of TRAV1-2+ and TNF-producing cells 124 
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in the lung (n=9) and intestinal mucosa (n=8, unmatched samples) where MAIT cells 125 
were initially found to be enriched3. The frequencies of TRAV1-2+ CD8+ T cells were 126 
similar across mucosal sites, associated lymphoid tissues and unmatched peripheral 127 
blood samples (n=6) (Fig. 1d).  In contrast, significantly higher frequencies of TRAV1-2+ 128 
cells from the lung produced TNF in response to M. smegmatis-infected cells compared 129 
with TRAV1-2+ cells from lymphoid tissues, small intestine, or peripheral blood (P = 130 
0.035, 0.0025, 0.0023 and 0.0005 (Mann Whitney U-test), Fig. 1e). Cell yields from 131 
these tissues were insufficient to establish functional dependence on MR1 as has been 132 
shown previously with this assay18.  Nonetheless, these data demonstrate that 133 
mycobacterial stimulation results in TNF production by donor-unrestricted, lung resident 134 
TRAV1-2+ CD8+ T cells.   135 
 136 
TRAV1-2+ CDR3 usage in Mtb-infected lung tissue 137 
On the basis of these results, we hypothesized that pulmonary infection with Mtb leads 138 
to the migration to and/or expansion of TRAV1-2+ CD8+ cells in the lung, potentially 139 
driven by Mtb-derived MR1 ligands. A hallmark of the human immune response to Mtb is 140 
the formation of lung granulomas. We therefore sought to determine the relevance of 141 
TRAV1-2+ T cell receptor (TCR) usage in lung granulomas from patients with TB. Single 142 
cell suspensions were prepared from diseased lung parenchyma from individuals (n = 5) 143 
undergoing clinically indicated surgical resection for complications of TB19. The most 144 
highly diseased lung granuloma (LG) tissues were designated "A" and the least 145 
diseased tissues designated "C." CD4- T cells from these samples were sorted by flow 146 
cytometry and subjected to high-throughput repertoire analysis using the bias-controlled 147 
immunoSEQ TCR sequencing platform20. In the 12 samples that yielded the minimal 148 
necessary sequencing data for analysis (>104 productive reads, yielding a median of 149 
3,919 unique productive TCR reads (range 397-28,792) and a median of 167 TRAV1-150 
2-utilizing unique productive TCR reads (range 19-1,081), the overall frequency of 151 
TRAV1-2+ TCR sequences in granulomas ranged from 3.1 to 5.9% across all donors 152 
and tissue samples (Fig. 2a and Supplementary Table 1).  These frequencies are similar 153 
to those observed in peripheral blood and lymph nodes.  We then developed an 154 
algorithm based on published MAIT CDR3 amino acid (aa) sequences16,21 to determine 155 
which of these TRAV1-2+ CDR3 sequences represented MAIT cell-consistent TCRs. 156 
A CDR3 sequence similarity analysis was performed using "MAIT Match" 157 
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(http://www.cbs.dtu.dk/services/MAIT_Match), a tool based on the method described by 158 
Shen et al,22 where a score of 1 reflects a perfect match and a score of 0 a perfect 159 
mismatch with published MAIT cell CDR3 sequences. To determine the validity of this 160 
tool, we compared the proportion of TRAV1-2+ sequences with the proportion of 161 
TRAV12-2+ sequences (an unrelated control) for TCRs with scores ranging from 0.85 to 162 
1. MAIT Match scores of 0.95 to 1 were significantly increased among the in TRAV1-2+ 163 
but not TRAV12-2+ TCR sequences (P = 0.0035, P = 0.00046, t-test; Fig. 2b). We 164 
therefore chose a MAIT Match score of 0.95 as a conservative threshold to define MAIT 165 
cell-consistent TCRs (Fig. 2b). In one individual with paired samples from the lung and 166 
mediastinal lymph node (LN), TRAV1-2 usage was comparable at both sites, but 167 
similarity analysis revealed MAIT cell-consistent TCR enrichment in the lung (P < 168 
0.0001; 2-way ANOVA; Fig. 2c).  169 
 170 
To address the possibility that Mtb drives the recruitment and/or expansion of TRAV1-2+ 171 
T cells with MAIT-consistent CDR3's in granulomatous tissue, we analyzed the MAIT 172 
cell-consistent CDR3 sequences (MAIT Match score 0.95-1) found in diseased lung 173 
parenchyma (n = 5 individuals, 11 samples). It is established that certain MAIT cell 174 
TCR chains can be shared among individuals (public sequences)23, while donor-unique 175 
(private) CDR3 sequences can be selected in response to distinct microbes16. As 176 
shown in Figure 2d, both private and public CDR3 sequences were detected among 177 
the MAIT cell-consistent CDR3 sequences present in granulomatous lung tissue 178 
isolated from patients with TB. Notably, public MAIT cell-consistent CDR3 were 179 
frequently encoded by multiple synonymous nucleotide sequences within individuals 180 
suggesting the expansion of multiple clones with the same CDR3 amino acid 181 
sequences (Fig. 2e, right). In contrast, private MAIT cell-consistent CDR3 sequences 182 
were encoded by individual nucleotide sequences suggesting that these were the result 183 
of expansions of a single MAIT cell clone in each donor (Fig. 2e, left). Private CDR3 184 
sequences were not restricted to infrequent clonotypes and in some tissue samples 185 
occurred as the dominant MAIT cell-consistent TCR.  186 
 187 
Bronchoalveolar TRAV1-2+ CD8+ T cells in active pulmonary TB 188 
Diminished frequencies of circulating MAIT cells have consistently been observed in 189 
people with TB4,5. This apparent peripheral depletion may occur as a consequence of 190 
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selective MAIT cell migration to the lung or may reflect increased host vulnerability to 191 
infection with Mtb. Having found that TRAV1-2+ CD8+ cells are enriched in healthy 192 
airways and respond to mycobacteria (Fig. 1e)4, we hypothesized that pulmonary 193 
infection with Mtb drives the accumulation and expansion of TRAV1-2+ CD8+ cells in the 194 
lung in response to Mtb-derived MR1 ligands. To address this possibility, we measured 195 
the frequency of TRAV1-2+ CD8+ T cells in bronchoalveolar (BAL) fluid samples obtained 196 
from individuals with untreated, active pulmonary TB and controls with no evidence of 197 
infectious or inflammatory pulmonary disease (Supplementary Table 2). In BAL fluid, 198 
TRAV1-2+ CD8+ T cells were significantly enriched in patients with TB at frequencies 199 
approximately 3-fold higher than controls (P = 0.0022, Mann-Whitney U test, Fig 3a).  200 
Conversely, in matched peripheral blood samples, TRAV1-2+ CD8+ T cells were 201 
significantly diminished in patients with TB at frequencies approximately 2-fold lower 202 
compared to healthy controls (P = 0.0028, Mann-Whitney U test, Fig 3a). To assess the 203 
functional capacity of TRAV1-2+ CD8+ T cells in the BAL fluid and matched peripheral 204 
blood samples, we utilized -CD2/CD3/CD28 beads as a stimulant to trigger responses 205 
via the TCR. Cell yields were insufficient to explore ligand-specific activation, which may 206 
also be subject to bias arising from compartment-specific differences in MR1-expression 207 
by antigen-presenting cells24. MAIT cells have been reported to produce IFN-γ, TNF, 208 
granzymes, granulysin, IL-17 and IL-22.25-27  Among these, we chose to measure TNF, a 209 
representative Th1 effector cytokine essential for immune control of Mtb28 and IL-17, an 210 
immunomodulatory cytokine reportedly produced in a TCR-independent manner by 211 
MAIT cells29. A significantly greater proportion of TRAV1-2+ CD8+ T cells in BAL fluid 212 
produced TNF (median 40%, range 36-91%) compared with TRAV1-2+ CD8+ T cells in 213 
matched peripheral blood samples (median 15%, range 4.7-27%) (P  = 0.004, Mann-214 
Whitney U test, Fig. 3b, 3c and Supplementary Figure 1).  In contrast fewer than 1% of 215 
TRAV1-2+ CD8+ T cells in the BAL fluid and only 2% in matched peripheral blood 216 
samples produced IL-17 (Supplementary Figure 2).  We therefore concluded that TCR 217 
triggering of these BAL-resident TRAV1-2+ CD8+ T cells does not evoke IL-17 218 
production, though other mitogenic or cytokine-associated stimulations may do so. Next, 219 
we characterized the phenotype of BAL resident TRAV1-2+ CD8+ T cells.  MAIT cells can 220 
be defined in peripheral blood by TRAV1-2 usage in conjunction with high-level 221 
expression of the c-type lectin CD161, and the di-peptidase CD26.13,27  In BAL fluid 222 
obtained from patients with TB, TRAV1-2+ CD8+ T cells expressed low levels of CD161 223 
compared with peripheral blood TRAV1-2+ CD8+ T cells (Fig. 3d), consistent with the 224 
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data from healthy lung tissue (Fig. 1c) and the prior demonstration that CD161 can be 225 
down-regulated as a result of MAIT cell activation 17,29,30. In contrast, TRAV1-2+ CD8+ T 226 
cells in the BAL fluid more consistently expressed CD26, which is abundantly present on 227 
all functional MR1-restricted MAIT cells in peripheral blood17,25. CD103, the E integrin 228 
associated with tissue-resident memory T cells31 was expressed variably but exclusively 229 
on BAL TRAV1-2+ CD8+ T cells. 230 
 231 
Although TRAV1-2 usage is a defining feature of MAIT cells, the same gene segment 232 
can be expressed by T cells recognizing mycobacterial ligands presented in the context 233 
of HLA-Ia molecules and CD1b32. On the basis that TRAV1-2+ CD8+ T cells display a 234 
surface phenotype suggestive of tissue-resident MAIT cells in BAL fluid isolated from 235 
patients with active TB, we postulated that the corresponding CDR3 sequences would 236 
provide a molecular signature reflecting MAIT cell enrichment relative to TRAV1-2+ CD8+ 237 
T cells in matched peripheral blood samples.  To test this hypothesis, we performed 238 
high-throughput TCR repertoire analysis of TRAV1-2+ CD4- T cells sorted by flow 239 
cytometry from cryopreserved BAL fluid and matched peripheral blood specimens 240 
obtained from three donors with active TB (Supplementary Table 3). MAIT cell-241 
consistent CDR3 sequences comprised a higher percentage of the TRAV1-2+ 242 
repertoire in BAL fluid compared with peripheral blood, irrespective of the parameter 243 
used to define MAIT cell-consistent CDR3 sequences, including assessment of 244 
similarity to published MAIT cell CDR3 sequences (MAIT Match score = 0.95 or 1) or 245 
according to usage of TRAJ12, TRAJ20 or TRAJ33 (Fig. 3e; P = 0.0036; 2-way 246 
ANOVA). Among the patients with TB, CDR3 sequences with the highest MAIT Match 247 
scores (> 0.95) were enriched in BAL fluid, while those with the lowest MAIT Match 248 
scores (< 0.85), were more frequent in peripheral blood (Fig. 3f).   249 
 250 
To determine the extent to which individual MAIT cell-consistent CDR3 sequences 251 
(MAIT Match Score > 0.95) were shared between these two anatomical compartments, 252 
we created a TCR Enrichment Analysis (TEA) webtool 253 
(https://github.com/eisascience/Wong-Gold-Lewinsohn) to enable visualization and 254 
weighted frequency analysis of the most common MAIT cell-consistent CDR3 255 
sequences in matched samples (Fig. 3g and Supplementary Table 4).  In all three 256 
patients, the most frequent MAIT cell-consistent CDR3 sequences were present in both 257 
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compartments, with disproportionate expansion in the BAL fluid compared with the 258 
peripheral blood.  In contrast, CDR3 sequences with low MAIT Match scores (<0.85) 259 
were generally expanded only in one anatomical compartment (Supplementary Figure 260 
4).  The selective expansion of MAIT cell-consistent CDR3 sequences in the lung 261 
compartment relative to peripheral blood suggests antigen-driven clonal expansion in 262 
response to pulmonary infection with Mtb.   263 
 264 
To determine if TRAV1-2+ CD8+ T cells present in BAL fluid contained MAIT cells, we 265 
examined the MR1-restricted function of T cell clones generated from a BAL fluid sample 266 
obtained from a patient with TB.  Six of these TRAV1-2+ clones (D0033-A1, A2, A3, A6, 267 
A8 and A10) expressed MAIT cell-consistent CDR3 sequences (MAIT Match score = 268 
0.98-1; Table 1).  Stimulation of these clones with HLA-mismatched M. smegmatis-269 
infected or Mtb-infected antigen-presenting cells induced robust IFN- while two control 270 
clones from the same patient (D0033-D7 and E7) failed to produce IFN under identical 271 
conditions.  In contrast, stimulation of the TRAV1-2+ clones with HLA-mismatched M. 272 
smegmatis-infected or Mtb-infected MR1-KO antigen-presenting cells33 resulted in 273 
negligible IFN-γ-production, thereby demonstrating MR1-depdendent cytokine 274 
production consistent with MAIT cell function (Fig. 3h).   275 
 276 
MR1 tetramer loaded with 5-OP-RU ligand has been shown to identify functional MAIT 277 
cells in the human peripheral circulation13. To evaluate whether TRAV1-2+ CD8+ T cells 278 
in the BAL of humans with TB could be stained by MR1/5-OP-RU tetramer, as well as 279 
the relationship between MAIT cell-consistent CDR3 usage and MR1/5-OP-RU 280 
tetramer staining, we took advantage of two donors with TB with available cryopreserved 281 
specimens.  We stained cells from paired BAL and peripheral blood samples with 282 
TRAV1-2 antibody, MR1/5-OP-RU tetramer and MR1/6-FP tetramer (negative control). 283 
As shown in Figure 4a, BAL cells from donor 1020 demonstrated MR1/5-OP-RU 284 
tetramer staining of 33.7% of the TRAV1-2+ cells, supporting the TCR sequencing 285 
analysis that found that 40.7% of BAL TRAV1-2 CDR3 sequences were MAIT cell-286 
consistent (MAIT Match score > .95). In the peripheral blood of this participant, only 287 
3.06% of the TRAV1-2+ peripheral cells demonstrated MR1/5-OP-RU tetramer staining, 288 
in line with the TCR sequencing analysis that had found that 5.09% of peripheral 289 
TRAV1-2 CDR3's were MAIT cell-consistent.  290 
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 291 
In contrast to MR1/5-OP-RU tetramer staining in the peripheral blood where positive and 292 
negative populations were clearly discernable, the MR1/5-OP-RU tetramer staining of 293 
BAL cells was of heterogeneous intensity and did not allow unambiguous delineation of 294 
MR1/5-OP-RU tetramer negative and positive populations. As a result, we sorted 295 
TRAV1-2+ cells based on MR1/5-OP-RU tetramer staining, subjected both positive and 296 
negative subsets to TCR sequencing, and analyzed MAIT cell-consistent CDR3 usage 297 
in each population (Table 2).  CDR chain sequencing of MR1/5-OP-RU tetramer 298 
positive cells from BAL and peripheral blood revealed that 93.9% and 89.2% of these 299 
respectively utilized MAIT cell-consistent TCRs. CDR chain sequencing of the MR1/5-300 
OP-RU tetramer negative TRAV1-2+ populations demonstrated that a substantial 301 
proportion (13.7%) of the MR1/5-OP-RU tetramer negative cells in the BAL utilized MAIT 302 
cell-consistent CDR chains.  In contrast, only 2.7% of MR1/5-OP-RU tetramer 303 
negative cells from the peripheral blood utilized MAIT cell-consistent CDR chains. 304 
These data suggest that MR1/5-OP-RU tetramer may perform less efficiently in BAL fluid 305 
than in peripheral blood.  Notably, in the other donor (91), in whom 28.5% of the TRAV1-306 
2+ cells had a MAIT cell-consistent CDR, only 5.09% of the TRAV1-2+ cells from the 307 
BAL stained MR1/5-OP-RU positive.  In this donor, 24.7% of the MR1/5-OP-RU tetramer 308 
negative cells had MAIT cell-consistent CDR chains, suggesting that MR1/5-OP-RU 309 
tetramer staining of BAL cells may underestimate the presence of MAIT cells as 310 
determined by CDR3 usage.  311 
 312 
To better understand the relationship between MR1/5-OP-RU tetramer staining, CDR 313 
usage and MR1-dependent T cell activity, we sorted MR1/5-OP-RU positive cells from 314 
the BAL of an available individual with non-TB pneumonia and performed limiting dilution 315 
cloning using anti-CD3 and IL-2 stimulation.  Following rapid expansion34, each clone 316 
was characterized functionally for MR1-restriction and antigenic specificity.  As shown in 317 
Figure 4c, four clones (D1004-B3, E1, E5, and H3) produced IFN- when stimulated with 318 
M. smegmatis-infected antigen presenting cells (A549) and abrogated IFN- production 319 
when stimulated with identically infected MR1-KO antigen presenting cells.33 TCR 320 
sequencing demonstrated that each of these clones utilized a MAIT cell-consistent 321 
CDR (Figure 4b).  Surprisingly, despite clear evidence of MR-1 restricted function, 322 
usage of MAIT cell-consistent CDR3's and TRAV1-2 staining of similar intensity (Fig. 323 
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4c), these clones demonstrated considerable heterogeneity in MR1/5-OP-RU tetramer 324 
staining, with two of the four clones staining weakly (Figure 4d).  325 
 326 
Discussion 327 
Collectively, our data indicate that donor-unrestricted mycobacterial-reactive TRAV1-2+ 328 
CD8+ T cells are present in the human respiratory mucosa and that pulmonary infection 329 
with Mtb leads to an enrichment of airway resident, pro-inflammatory TRAV1-2+ CD8+ 330 
cells including oligoclonal expansions of MAIT cells.  331 
 332 
In lung tissue explanted from healthy organ donors, we find that TRAV1-2+ CD8+ T cells 333 
localize to the respiratory tract mucosal surface.  In contrast to their counterparts in the 334 
gut mucosa, TRAV1-2+ CD8+ T cells from the respiratory mucosa produce TNF in 335 
response to mycobacterial stimulation by donor-unrestricted antigen-presenting cells.  336 
This suggests that TRAV1-2+ CD8+ T cells in the airway mucosa may play a role in anti-337 
Mtb immunity by initiating a local pro-inflammatory response upon exposure to 338 
aerosolized Mtb. 339 
 340 
In the setting of active pulmonary tuberculosis, we observed striking expansions of 341 
TRAV1-2+ CD8+ T cells in the bronchoalveolar compartment. Compared to paired 342 
peripheral blood TRAV1-2+ CD8+ T cells, the bronchoalveolar TRAV1-2+ CD8+ T cells 343 
produced significantly more TNF.  Some, but not all, of these expanded bronchoalveolar 344 
TRAV1-2+ CD8+ T cells could be identified as MAIT cells based on their utilization of 345 
MAIT cell-consistent CDR3 chains, demonstration of MR1-restricted function or 346 
selective binding of the MR1/5-OP-RU tetramer.  It should be noted that among the 347 
TRAV1-2+ CD8+ T cells that could not be unequivocally confirmed as MAIT cells we 348 
identified subpopulations that displayed certain "MAIT-like" features, such as high-level 349 
expression of CD26 or oligoclonal expansions of TRAV1-2+ TCR chains with features 350 
similar to MAIT cell CDR3 sequences (incorporation of the TRAJ12, TRAJ20 or 351 
TRAJ33 segments, or the presence of the Tyr95 which is known to be critical for MAIT 352 
cell TCR binding to MR1-restricted ligands35).  Our attempts to clone these populations 353 
have been unsuccessful to date, such that further work will be required to determine if 354 
these TRAV1-2+ CD8+ T cells with "MAIT-like" features are restricted by MR1.  It is also 355 
notable that MR1/5-OP-RU tetramers identified only a subset of TRAV1-2+ CD8+ T cells 356 
with MAIT cell-consistent CDR3a's.   357 
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 358 
We postulate that variable MR1-tetramer staining observed on bronchoalveolar TRAV1-359 
2+ CD8+ cells could reflect a state of activation among tissue resident cells.  Supporting 360 
this, we note that differential tetramer staining can be observed following expansion of 361 
MAIT cell clones with activating cytokines (data not shown).  Alternatively, we postulate 362 
that TRAV1-2+ CD8+ T cells with MAIT cell-consistent CD3's may have altered 363 
tetramer-binding avidity as a result of differential affinity of their TCRs for MR1-ligands.  364 
This possibility is suggested by the variable magnitude of response to M. smegmatis in 365 
the functional assay, and has recently been demonstrated for the photolumazine I 366 
ligand36.  Further work will be required to better understand the relationship between 367 
TCR-dependent MR1-dependent activation, MR1/5-OP-RU tetramer staining, and ligand 368 
selectivity among bronchoalveolar TRAV1-2+ CD8+ T cells.  At this point we conclude 369 
that MR1/5-OP-RU tetramer staining of bronchoalveolar MAIT cells is weaker and more 370 
variable than MR1/5-OP-RU tetramer staining of peripheral blood MAIT cells and hence 371 
may underestimate MAIT cell prevalence in the BAL.   372 
 373 
In contrast to the bronchoalveolar fluid of active TB patients, analysis of TCR chain 374 
usage in granulomas of patients undergoing lung-resection for clinically complicated 375 
tuberculosis did not demonstrate dramatic expansions of TRAV1-2+ TCR's.  The 376 
contrast between the enrichment of TRAV1-2+ CD8+ T cells observed in bronchoalveolar 377 
lavage fluid and the relatively low frequencies of TRAV1-2+ TCRs found in the lung 378 
granuloma tissue may be due to differences between cells present in the airway mucosal 379 
environment and in lung parenchymal tissue.  It is also possible that the kinetics of 380 
expansion of TRAV1-2+ CD8+ cells with MAIT cell-consistent CDR3's varied during the 381 
long course of TB disease and anti-tuberculosis therapy that preceded surgical 382 
treatment in these medically-complex lung-resection patients.  383 
 384 
It is therefore notable that even in the resected granuloma tissue, the subset of TCR's 385 
with MAIT cell-consistent sequences was enriched among the TRAV1-2+ CDR3's in 386 
lung granuloma tissue compared to paired mediastinal lymph node tissue.  We postulate 387 
that this relative enrichment of MAIT cell-consistent TCRs among TRAV1-2+ sequences 388 
from the lung was driven by local antigen exposure, while acknowledging that tissue-389 
specific non-antigen stimuli could also lead to the independent expansion of clones in 390 
the lung compartment.  Further understanding of this will require additional organ-391 
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specific datasets to allow comparison of diseased and reference TCR repertoires. We 392 
found both public and private MAT cell-consistent CDR3 chains in the TB-infected 393 
human lung tissues we analyzed.  Interestingly, public MAIT cell-consistent CDR3 394 
chains were frequently encoded by multiple synonymous nucleotide sequences within an 395 
individual sample. This finding is consistent with a previous report implicating convergent 396 
recombination as a determinative process in the generation of public MAIT cell CDR3 397 
sequences23, and suggests that tissue-resident public MAIT cell-consistent CDR3 398 
expansions are the result of multiple individual MAIT cells clonally expanding in infected 399 
tissues. The significance of cells with private MAIT cell-consistent CDR3 chains in the 400 
context of Mtb-jnfected tissue remains uncertain.  One possibility is that public and 401 
private MAIT cell-consistent CDR3 chains have similar ligand-binding properties, such 402 
that utilization and expansion of specific clonotypes in individual hosts is the result of 403 
differences in the naive TCR repertoire and is not driven by specific microbial exposures. 404 
Alternatively, the observed clonal expansion of private MAIT cell-consistent clonotypes 405 
within Mtb infected tissue may reflect selective expansions in response to the local 406 
presence of microbe-derived ligands presented by MR136. A third possibility is that 407 
because our sample set is small, sequences that appear to be private in this analysis 408 
could in fact turn out to be public when larger numbers of individual donors are sampled.  409 
In order to determine the significance of private and public MAIT cell-consistent TCRs in 410 
the context of mycobacterial infection, further study of selective ligand specificity in 411 
larger numbers of donors is needed. Nonetheless, the convergence of multiple 412 
nucleotide rearrangements on expanded public MAIT cell-consistent TCR chains 413 
suggests that in some instances, multiple MAIT cells with genetically unique but 414 
functionally similar TCR chains clonally expand in the TB-infected lung, potentially in 415 
response to microbe-derived antigenic-stimulation.  416 
 417 
In line with recent studies that have found MAIT cell expansions in the lungs of mice 418 
experimentally infected with Mtb37 and S. enterica serovar Typhimurium (S. 419 
Typhimurium)38, we found expansions of TRAV1-2+ CD8+ T cells with MAIT or MAIT-like 420 
features in the BAL and lung parenchyma in patients with TB. Supported by the findings 421 
Chen et al who found that accumulation of MAIT cells in the lungs of mice following 422 
challenge with S. Typhimurium is dependent on antigen derived from the microbial 423 
riboflavin synthesis pathway38, we postulate that these TRAV1-2+ CD8+ cell enrichments 424 
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contain MAIT cells and are driven by Mtb-derived small molecular ligands. Howson et al 425 
recently reported that MAIT cell clones with more avid ligand binding expand during S. 426 
enterica serovar Paratyphi A infection and that these clones remain expanded after 427 
treatment of the infection39. This finding supports the idea that exposure to microbe-428 
derived MR1 ligands alters the human MAIT cell TCR repertoire and suggests a role for 429 
MR1-ligand vaccine strategies. Overall our findings suggest a previously unrecognized 430 
and potentially important role for TRAV1-2+ CD8+ T cells with MAIT or MAIT-like features 431 
in the immune response to aerosolized Mtb infection, and would support exploration of 432 
these cells as targets of either vaccination or immunotherapeutic strategy. 433 
 434 
Methods 435 
 436 
Human subjects 437 
Samples from Portland, Oregon, USA. Airway, lung, small intestine and associated 438 
lymph node tissues ineligible for transplantation were obtained from the Pacific 439 
Northwest Transplant Bank under a protocol approved by the Institutional Review Board 440 
at Oregon Health & Science University.  Limited clinical information was available for 441 
these individuals, who were generally considered healthy prior to demise. For 442 
comparison with the organ samples, PBMCs were obtained by apheresis from healthy 443 
adult donors providing informed consent.   444 
Samples from Durban, South Africa. Explanted granulomatous lung tissue and 445 
associated lymph nodes were obtained under a protocol approved by the University of 446 
KwaZulu Natal Human Biomedical Research Ethics Commitee (UKZN BREC) allowing 447 
adults undergoing clinically indicated lung resection for complicated tuberculosis at 448 
Inkosi Albert Luthuli Central Hospital (IALCH) to donate excess tissue for scientific 449 
research.19  Tissue was isolated from different areas of resected lungs based on the 450 
experience of the operating surgeon and the preoperative radiological data. Clinical 451 
characteristics of the individuals and samples have been described19. All donors 452 
provided written informed consent prior to surgery.  BAL fluid and paired peripheral 453 
blood samples were obtained under a protocol approved by the UKZN BREC and 454 
Partners Institutional Review Board allowing collection of excess fluid from adult patients 455 
undergoing clinically indicated diagnostic bronchoscopies at IALCH. Active tuberculosis 456 
was defined microbiologically (positive BAL Mtb culture or BAL Mtb PCR by GeneXpert) 457 
and/or histologically (Ziehl-Neelsen positive necrotizing granulomas on transbronchial 458 
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biopsy obtained at the time of BAL). Uninfected controls were defined as individuals with 459 
no evidence of either infectious or inflammatory lung disease, as determined by a 460 
committee of study physicians on the basis of clinical history, chest x-rays, computerized 461 
tomography scans, and negative BAL microbiology (mycobacterial, bacterial and fungal 462 
cultures, and Mtb PCR). Most controls underwent bronchoscopy for suspected lung 463 
cancer, and a non-cancerous segment was lavaged in these cases.  All donors provided 464 
written informed consent prior to bronchoscopy. Cryopreserved peripheral blood 465 
mononuclear cells (PBMCs) from healthy donors (defined as asymptomatic and HIV-466 
negative with no evidence of Mtb by ELISPOT) were available from the iThimba Cohort 467 
which was approved by the UKZN BREC and Partners Institutional Review Board40. All 468 
participants provided written informed consent.   469 
 470 
Isolation and stimulation of lung and gut T cells  471 
Lymphocytes were isolated from fresh lung tissue as described previously4. A two-step 472 
process was used to extract cells from the small intestine. For collection of lymphocytes 473 
from the intraepithelial (IEL) layer, the tissue was washed in HBSS, stripped of muscle, 474 
and incubated with agitation for 30 minutes in 0.15% dithiothreitol (Sigma-Aldrich). IEL 475 
lymphocytes were then harvested, and the remaining tissue was incubated for 30 476 
minutes in PBS.  Lamina propria (LP) lymphocytes were released by digestion with 0.1% 477 
collagenase (CLS-3, Worthington) and 0.3% DNAse (Roche) for 30 minutes at 37º C. 478 
IEL and LP preparations were further enriched over a discontinuous Percoll gradient. 479 
Lymphocyte stimulations were performed as described previously4,12,16. Briefly, 480 
lymphocytes were incubated for 16 hours with uninfected (control) or M. smegmatis 481 
strain mc2122-infected (multiplicity of infection = 3) A549 cells (ATCC CCL-185) at a 482 
ratio of 3:1 in the presence of -CD28 and -CD49d (Biolegend), together with an -483 
TNF mAb (Beckman Coulter) and the TNF-Processing Inhibitor 0 (TAPI-0, 10 μM) 484 
(Calbiochem). Cells were then stained as described above for surface expression of 485 
CD45, CD3, CD8, TRAV1-2, and CD1614. Dead cells were excluded using Aqua 486 
LIVE⁄DEAD (Invitrogen). Stained samples were acquired on a Fortessa flow cytometer 487 
(BD Biosciences) and data were analyzed with FlowJo software version 10.6 (Tree Star). 488 
 489 
Immunohistochemistry of airway tissues 490 
Cryosections (10 µM) of frozen airway tissues were treated with acetone and air-dried 491 
prior to incubation with -TRAV1-2 antibody (clone-3C10; Biolegend) followed by goat -492 
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mouse IgG1-Alexa Fluor 488 (1:1000), and then -CD8 antibody (1:50; LSBio) followed 493 
by goat -mouse IgG1-Alexa Fluor 568 (1:1000). Sections were washed and stained 494 
with DAPI. Images were acquired using an Olympus FluoView FV1000 laser scanning 495 
confocal microscope system with a 40 x 1.3 Oil Plan Fluorite objective. Confocal images 496 
were analyzed using Imaris Analysis Software. 497 
 498 
Isolation and TCR sequencing of T cells from lung granulomas 499 
Diseased lung tissue (approximately 3 cm3) was isolated from surgically resected 500 
explants. Each sample was washed in multiple changes of Hank's Balanced Salt 501 
Solution (HBSS), diced into smaller pieces (approximately 1 mm3), strained, 502 
resuspended in pre-warmed R10 supplemented with 0.5 mg/ml collagenase D (Roche) 503 
and 40 U/ml DNaseI (Roche), and transferred to GentleMACS C-tubes (Miltenyi Biotec) 504 
for mechanical digestion per the manufacturer’s instructions. The resulting suspension 505 
was incubated for 60 minutes at 37oC, subjected to an additional mechanical digestion 506 
step, strained through a 70 m filter, washed twice in HBSS, and stained prior to sorting 507 
CD4– T-cells using a FACSARIA flow cytometer (BD Biosciences). Cells were gated as 508 
live (nearIR–, Invitrogen), single lymphocytes (determined on the basis of light scatter), 509 
then sorted as CD45+, CD3+, CD4- events directly into RLT buffer. Genomic DNA was 510 
extracted using a DNeasy Minikit (Qiagen) and high-throughput TCR sequencing was 511 
performed using the ImmunoSEQ assay (Adaptive Biotechnologies Corp.)41. Data were 512 
analyzed using the ImmunoSEQ Analyser. 513 
 514 
CDR3 sequence similarity 515 
Similarity between CDR3 sequences was calculated as described previously22. This 516 
method allows similarities to be assigned between sequences of different length in an 517 
alignment-free manner. An implementation of the similarity matching between CDR3 518 
sequences is publicly available at http://www.cbs.dtu.dk/services/MAIT_Match. The 519 
server takes as input a list of CDR3 sequences, and returns for each a score based on 520 
the maximal sequence similarity with a reference database of MAIT cell CDR3 521 
sequences. A perfect match has a similarity score of 1, and a perfect mismatch a 522 
similarity score of 0.   523 
 524 
Collection, staining and stimulation of BAL lymphocytes 525 
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Bronchoscopies were performed by pulmonologists at IALCH.  Patients received 526 
sedation and bronchodilators according to the local standard of care; Normal saline (200 527 
mL) was lavaged into the lobe with the highest burden of pathology or, in patients with 528 
diffuse disease, the right middle lobe. Available BAL fluid was combined in a 1:1 ratio 529 
with R10 (RPMI 1640 supplemented with 10% fetal bovine serum, L-glutamine, penicillin 530 
and streptomycin) and stored on ice. All samples were processed within 3 hours of 531 
collection, BAL fluid was filtered through a 40 µm strainer (BD Pharmingen) and 532 
centrifuged.  Resuspended BAL cells were aliquoted for staining with Aqua LIVE⁄DEAD 533 
(Invitrogen) and some or all of the following antibodies:  -CD3-PE-CF594 (BD Horizon, 534 
clone UCHT1), -CD8-APC-H7 (BD Pharmingen, clone SK1), -CD14-PerCP-Cy5.5 535 
(BioLegend, clone HCD14), -CD235a-PerCP-Cy5.5 (BioLegend, clone HIR2), -536 
TRAV1-2-APC (clone OF-5A1212), -CD161-PE-Cy7 (BioLegend, clone HP-3G10), -537 
CD26-PE (BioLegend, clone BA5b).  All stains were performed at 4°C. Cells were then 538 
fixed with 4% paraformaldehyde. Functional studies were performed if sufficient 539 
numbers of BAL lymphocytes were available. After depletion of macrophages via plastic 540 
adherence for 1 hour, 1x106 lymphocytes were stimulated for 18 hours at 37oC with -541 
CD2/CD3/CD28-loaded Anti-Biotin MACSiBead Particles (Miltenyi Biotec) at a ratio of 542 
2:1 in RPMI 1640 supplemented with 10% fetal bovine serum, L-glutamine, HEPES, 543 
penicillin, and streptomycin. Brefeldin A was added after the first hour to inhibit protein 544 
transport from the endoplasmic reticulum.  Stimulated and unstimulated cells were then 545 
stained with Aqua LIVE⁄DEAD (Invitrogen) and the following antibodies: -CD235a-546 
PerCP-Cy5.5, -CD14-PerCP-Cy5.5, -CD8-APC-H7, -TRAV1-2-APC, -CD161-PE-547 
Cy7. After a wash step, cells were fixed with PERM/FIX Medium A (Invitrogen), 548 
permeabilized with PERM/FIX Medium B (Invitrogen), and stained with the following 549 
antibodies: -CD3-PE-CF594, -TNFa-PE (Beckman Coulter, clone IPM2), and -IL-17-550 
BV421 (BioLegend, clone BL168). Stained samples were acquired using a Fortessa flow 551 
cytometer (BD Bioscience). Rainbow Fluorescent Particles (BD Bioscience) and 552 
applications settings in FACSDiva7 were used to correct for day-to-day variations in 553 
instrument performance. Cells were gated as live (aqua viability dye negative) 554 
lymphocytes (determined on the basis of light scatter), and CD14++ cells were excluded 555 
prior to selecting CD3+ cells for analysis. Paired peripheral blood samples were collected 556 
where possible and freshly isolated PBMC were processed in parallel with matched BAL 557 
cells. Data were analyzed with FlowJo10.6 (Treestar).  Background cytokine production 558 
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was subtracted to calculate percentage of cells producing cytokine in response to 559 
stimulation.  When available, paired cryopreserved BAL and PBMC cells were thawed 560 
and stained with some or all of the above antibodies and MR1/5-OP-RU or MR1/6-FP 561 
tetramers (courtesy of the McCluskey Laboratory).  Cell suspensions were acquired and 562 
sorted on a FACSARIA flow cytometer (BD Biosciences) into TRIzol (Invitrogen).  563 
Genomic DNA was extracted utilizing the phenol-chloroform method according to 564 
manufacturer protocol, using linear acrylamide (Invitrogen) as a carrier.  High-throughput 565 
TCR sequencing was performed using the ImmunoSEQ assay (Adaptive 566 
Biotechnologies Corp)41. 567 
 568 
Visualization of MAIT cell CDR3 sequences 569 
Data were coded in R using the packages RColorBrewer, Shiny, data.table, ggplot2, and 570 
dplyr. Synonymous nucleotide sequences within a tissue were counted, and the 571 
associated frequencies are summed. These frequencies were visualized using the TCR 572 
Enrichment Analysis (TEA) webtool the code for which is archived at 573 
https://github.com/eisascience/Wong-Gold-Lewinsohn/tree/v1.0.0 574 
 575 
Generation and characterization of T cell clones 576 
Cells from BAL samples were stained with Aqua LIVE/DEAD (Invitrogen), MR1/5-OP-RU 577 
tetramer (0.3nM, McCluskey Laboratory), -CD4-FITC (clone OKT4; BioLegend), and -578 
CD8-APC-Cy7 (clone SK8; BioLegend). Live tetramer-binding cells were sorted by the 579 
basis of co-receptor expression using an Influx flow cytometer (BD Biosciences), rested 580 
overnight in RPMI 1640 supplemented with 10% heat-inactivated pooled human serum 581 
and 0.5ng/ml rhIL-2, and then distributed in limiting dilution format with irradiated PBMCs 582 
(150x105/well) and irradiated B-lymphoblastoid cells (3x104/well) in a 96-well round 583 
bottom plate. The cultures were stimulated with rhIL-2 (5ng/ml), rhIL-12 (0.5ng/ml), rhIL-584 
7 (0.5ng/ml), rhIL-15 (0.5ng/ml) and -CD3 (0.03 µg/ml). Clones were harvested after 585 
incubation for 20 days at 37oC and assessed for clonality by flow cytometry, TCR 586 
sequencing, and MR1-restricted function by ELISPOT.  587 
 588 
Nitrocellulose-backed multiscreen 96-well plates (Millipore) were coated overnight at 4°C 589 
with a 10 µg/ml solution of -IFN antibody (clone 1-D1K; Mabtech) in 0.1 M Na2CO3, 590 
0.1 M NaHCO3, pH 9.6. The plate was washed three times with sterile PBS and blocked 591 
for 1 hour at room temperature with RPMI 1640 containing 10% heat-inactivated pooled 592 
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human serum. Uninfected, M. smegmatis mc2122-infected (multiplicity of infection = 3), 593 
or M. tuberculosis H37Rv-infected (multiplicity of infection = 30) wildtype or MR1-null33 594 
A549 cells (1 x 104/well) and clonal T cells (1 x 104/well) were added and incubated 595 
overnight at 37°C. The plates were then washed six times in PBS containing 0.05% 596 
Tween-20, incubated for 2 hours at room temperature with a 1 µg/ml solution of -IFN-597 
biotin antibody (clone 7-B6-1; Mabtech) in PBS containing 0.5% bovine serum albumin 598 
and 0.05% Tween-20, washed again six times in PBS containing 0.05% Tween-20 599 
followed by PBS alone, and developed using an AEC Vectastain Kit (Vector 600 
Laboratories). Spots were counted using an automated ELISPOT Reader System 601 
(Autoimmun Diagnostika GmbH). 602 
  603 
TCR sequence analysis of CD8+ T cell clones isolated from BAL fluid 604 
For some clones, total RNA was extracted using an RNeasy Mini Kit (Qiagen).  605 
Unbiased amplification of all expressed TRA and TRB gene products was then 606 
conducted using a template-switch anchored RT-PCR with chain-specific constant 607 
region primers42. Amplicons were sub-cloned, sampled, sequenced and analyzed as 608 
described previously43. Gene usage was assigned according to the IMGT nomenclature. 609 
For other clones, genomic DNA was extracted using a DNeasy Mini Kit (Qiagen) and 610 
high-throughput TCR and TCR sequencing was performed using the ImmunoSEQ 611 
assay (Adaptive Biotechnologies Corp)41. Data were analyzed using the ImmunoSEQ 612 
Analyser. 613 
 614 
Statistics and Reproducibility 615 
Statistical analyses were performed using Prism 6 (GraphPad Software Inc). The non-616 
parametric Mann-Whitney U test was used to assess differences between groups unless 617 
indicated otherwise. All statistitical tests were two-sided unless indicated otherwise. P 618 
values < 0.05 were considered significant for direct comparisons. In cases of multiple 619 
comparisons the Bonferonni correction was applied.  All antibodies were obtained 620 
commercially and not validated independently.  Cell lines tested negative for 621 
mycoplasma contamination. 622 
 623 
Code Availability 624 
Custom code for the MAIT Match tool is available at 625 
http://www.cbs.dtu.dk/services/MAIT_Match/.  Custom code for the visualization of 626 
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frequencies of specific TCR's in the TB granuloma tissues and the TCR Enrichment 627 
Analysis (TEA) webtool are archived at https://github.com/eisascience/Wong-Gold-628 
Lewinsohn 629 
 630 
Data Availability Statement 631 
The datasets generated during and/or analyzed during the current study are archived at 632 
https://github.com/eisascience/Wong-Gold-Lewinsohn or available from the 633 
corresponding author on reasonable request. 634 
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FIGURE LEGENDS 682 
 683 
Figure 1. TRAV1-2+ CD8+ T cells from the lung but not the intestine of healthy 684 
organ donors respond to mycobacterial infection by producing TNF.  685 
a.  Dot plots showing the frequency of TRAV1-2+ CD8+ T cells among live CD3+ cells in 686 
the indicated tissue samples from one donor.  687 
b. Tissue sections from the 1st and 2nd order bronchi were obtained from healthy 688 
individuals (n = 3 biologically independent samples). Immunohistochemistry was 689 
performed to quantify CD8+ (median 1.6 x 104 vs. 2x104 cells /mm3) and TRAV1-2+ cells 690 
(7,000 vs. 4,000 cells/mm3). Representative sections from 1st and 2nd order bronchi are 691 
depicted (left), showing CD8+ cells (red), TRAV1-2+ cells (green) and cell nuclei (DAPI; 692 
blue). 693 
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c. Histograms depicting TNF production (left) and CD161 expression (right) by TRAV1-694 
2+ CD8+ T cells from matched lung parenchyma (green), small intestine lamina propria 695 
(LP; blue) and the small intestinal intraepithelial layer (IEL; violet) after overnight 696 
stimulation with M. smegmatis-infected antigen-presenting cells (dotted black line 697 
indicates the unstimulated control).  698 
d. Frequency of TRAV1-2+ cells among CD8+ T cells from lung (n=9 biologically 699 
independent samples), mediastinal lymph node (Med LN; n=11 biologically independent 700 
samples), IEL (n=7 biologically independent samples), LP (n=8 biologically independent 701 
samples), mesenteric lymph node (Mes LN, n=5 biologically independent samples), and 702 
peripheral blood (PBMC; n=6 biologically independent samples). Medians and 703 
interquartile ranges are displayed.  704 
e. Frequency of TNF-producing TRAV1-2+ CD8+ T cells after exposure to M. smegmatis-705 
infected antigen-presenting cells: lung (n=7 biologically independent samples), Med LN 706 
(n=6 biologically independent samples), IEL (n=5 biologically independent samples), LP 707 
(n=6 biologically independent samples), Mes LN (n=2 biologically independent samples), 708 
PBMC (n=12 biologically independent samples). From top to bottom, P = 0.035, 0.0025, 709 
0.0023 and 0.0005 (Mann Whitney U-test). Medians and interquartile ranges are 710 
displayed. 711 
 712 
Figure 2. Expansions of MAIT cell-consistent CDR3's are present in tuberculous 713 
lung granulomas. 714 
a. Frequency of TRAV1-2+ sequences as a percentage of all productive TCR 715 
sequences. LG, lung granuloma; LN, lymph node. In some cases, multiple areas of 716 
tissue were sampled, ranging from closest (A) to furthest (C) from the site of disease. 717 
b. MAIT cell TCR sequences are consistent with similarity scores of 0.95 and 1. Each 718 
symbol represents the frequency of TRAV1-2+ or TRAV12-2+ sequences within each 719 
similarity score for each donor sample (n= 12 biologically independent samples).   720 
c. Frequency of total TRAV1-2+ sequences or those with similarity scores of 0.95 and 1 721 
in the lung and mediastinal lymph node (LN) from donor 23.   722 
d. Frequencies among TRAV1-2+ sequences of the top 10 public and private MAIT cell 723 
CDR3 sequences (MAIT Match score > 0.95) across individual donors and lung 724 
samples.  725 
e. Variation in the number of synonymous nucleotide sequences encoding the five most 726 
frequent private (left) and public (right) MAIT cell CDR3 amino acid (aa) sequences 727 
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from all samples displayed in Fig. 3d. For each aa sequence, each colored bar 728 
represents a different nucleotide sequence. The 13 different nucleotide sequences used 729 
to generate the shared MAIT cell CDR3 aa sequence CAVLDSNYQLIW are displayed. 730 
Text color represents nucleotide origin: purple (TRAV), black (TRAD or n insertion), red 731 
(TRAJ). 732 
 733 
Figure 3. TNF-producing TRAV1-2+ CD8+ cells including oligoclonally expanded 734 
MAIT cells are enriched in BAL fluid from patients with TB. 735 
a. Frequency of TRAV1-2+ cells among CD8+ T cells from the BAL fluid from patients 736 
with TB (n=6 biologically independent samples) and cancer controls (n=6 biologically 737 
independent samples), and among CD8+ T cells in matched peripheral blood samples 738 
(PBMC) from patients with TB (n=5 biologically independent samples) and unmatched 739 
peripheral blood samples from healthy controls (n=13 biologically independent samples). 740 
Medians and interquartile ranges are displayed. **P < 0.01; Mann-Whitney U-test. 741 
b. Dot plots showing TNF production by TRAV1-2+ CD8+ T cells in matched BAL and 742 
peripheral blood samples (PBMC) from a patient with TB. Cells were stimulated with 743 
 beads. 744 
c. Frequency of TNF or IL-17 production by TRAV1-2+ CD8+ T cells in matched BAL and 745 
peripheral blood samples (PBMC; n=5 biologically independent samples). Medians and 746 
interquartile ranges are displayed. **P < 0.01; Mann-Whitney U-test. 747 
d. Expression of CD161, CD26 and CD103 on TRAV1-2+ CD8+ T cells in matched BAL 748 
and peripheral blood samples (PBMC) from patients with TB (n=4). Histograms are 749 
mode-normalized. 750 
e. Frequency of MAIT cell CDR3 sequences within TRAV1-2+ CD4- T cells in BAL fluid 751 
and peripheral blood samples (PBMC) from patients with TB (n=3 biologically 752 
independent samples).  753 
f. Relative frequency of CDR3 sequences by MAIT Match Score category in BAL fluid 754 
vs. matched peripheral blood (PBMC; n=3 biologically independent samples). 755 
g. Depiction of the top 10 most frequent MAIT cell CDR3 sequences (MAIT Match 756 
score > 0.95) among TRAV1-2+ sequences in each compartment.  Legend format: 757 
CDR3 aa (# of synonymous nucleotide sequences in peripheral blood, # of 758 
synonymous nucleotide sequences in BAL fluid). 759 
h. IFN spot-forming units (SFU) produced by BAL T cell clones stimulated with M. 760 
smegmatis-infected or Mtb-infected wildtype (WT) or MR1-KO A549 cells.  761 
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 762 
Figure 4. Heterogeneous MR1/5-OP-RU staining of bronchoalveolar TRAV1-2+ 763 
CD8+ T cells with MAIT cell-consistent CDR's and MR1-restricted function 764 
a. Frequency of MR1-tetramer+ cells (loaded with active (5-OP-RU) and control (6FP) 765 
ligand) in TRAV1-2+ T cells (gated on live, CD3+, CD8+ lymphocytes) from the BAL fluid 766 
and peripheral blood of a patient with TB. The proportion of cells utilizing MAIT cell-767 
consistent CDR's (MAIT Match Score > 95) in MR1/5-OP-RU tetramer positive and 768 
negative populations are shown.  769 
b. IFN spot-forming units (SFU) produced by four T cell clones generated from BAL fluid 770 
and stimulated with M. smegmatis-infected wildtype (WT) or MR1-KO A549 cells.  771 
c. -TRAV 1-2 staining of four T cell clones generated from BAL fluid demonstrates 772 
consistent staining. Histograms are mode-normalized. 773 
d. Binding of MR1/5-OP-RU tetramer on the same four T cell clones generated from BAL 774 
fluid demonstrates heterogenous MR1/5-OPRU tetramer staining (left).  Binding of 775 
MR1/6-FP (control) and MR1/5-OPRU tetramer is shown for two clones (right). 776 
Histograms are mode-normalized. 777 
 778 
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SUPPLEMENTARY FIGURES 781 
1. Supplementary Figure 1. Representative gating strategy for TRAV1-2+ CD8+ T cells 782 
from bronchoalveolar lavage fluid 783 
2. Supplementary Figure 2. Extended intracellular cytokine staining 784 
3. Supplementary Figure 3. Comparison of CDR3 sequences with MAIT Match scores 785 
> 0.95 vs. MAIT Match scores < 0.85  786 
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SUPPLEMENTARY TABLES 788 
1. Supplementary Table 1. Yield of high-throughput repertoire analysis using the 789 
immunoSEQ TCR sequencing platform on lung granuloma samples from humans with 790 
TB infection. 791 
2. Supplementary Table 2. Characteristics of tuberculosis patients and BAL controls.  792 
3. Supplementary Table 3. Characteristics of tuberculosis patients whose cryopreserved 793 
paired BAL and PBMC samples were sorted to generate the data presented in Figure 794 
3e-g. 795 
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4. Supplementary Table 4. Top 15 MAIT CDR3 sequences in the bronchoalveolar 796 
lavage of humans with pulmonary tuberculosis. 797 
  798 
 26 
References. 799 
 800 
1 Porcelli, S., Yockey, C. E., Brenner, M. B. & Balk, S. P. Analysis of T cell 801 
antigen receptor (TCR) expression by human peripheral blood CD4-8- 802 
alpha/beta T cells demonstrates preferential use of several V beta 803 
genes and an invariant TCR alpha chain. J Exp Med 178, 1-16 (1993). 804 
2 Tilloy, F. et al. An invariant T cell receptor alpha chain defines a novel 805 
TAP-independent major histocompatibility complex class Ib-restricted 806 
alpha/beta T cell subpopulation in mammals. The Journal of 807 
experimental medicine 189, 1907-1921 (1999). 808 
3 Treiner, E. et al. Selection of evolutionarily conserved mucosal-809 
associated invariant T cells by MR1. Nature 422, 164-169, 810 
doi:10.1038/nature01433 (2003). 811 
4 Gold, M. C. et al. Human Mucosal Associated Invariant T Cells Detect 812 
Bacterially Infected Cells. PLoS Biol 8, e1000407 (2010). 813 
5 Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated 814 
invariant T cells. Nature immunology 11, 701-708, doi:10.1038/ni.1890 815 
(2010). 816 
6 Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to 817 
MAIT cells. Nature 491, 717-723, doi:10.1038/nature11605 (2012). 818 
7 Georgel, P., Radosavljevic, M., Macquin, C. & Bahram, S. The non-819 
conventional MHC class I MR1 molecule controls infection by Klebsiella 820 
pneumoniae in mice. Molecular immunology 48, 769-775, 821 
doi:10.1016/j.molimm.2010.12.002 (2011). 822 
8 Chua, W. J. et al. Polyclonal mucosa-associated invariant T cells have 823 
unique innate functions in bacterial infection. Infection and immunity 824 
80, 3256-3267, doi:10.1128/IAI.00279-12 (2012). 825 
9 Meierovics, A., Yankelevich, W. J. & Cowley, S. C. MAIT cells are critical 826 
for optimal mucosal immune responses during in vivo pulmonary 827 
bacterial infection. Proceedings of the National Academy of Sciences of 828 
the United States of America 110, E3119-3128, 829 
doi:10.1073/pnas.1302799110 (2013). 830 
10 Meierovics, A. I. & Cowley, S. C. MAIT cells promote inflammatory 831 
monocyte differentiation into dendritic cells during pulmonary 832 
intracellular infection. The Journal of experimental medicine 213, 2793-833 
2809, doi:10.1084/jem.20160637 (2016). 834 
11 Martin, E. et al. Stepwise Development of MAIT Cells in Mouse and 835 
Human. PLoS Biology 7, e54 (2009). 836 
12 Gold, M. C. et al. Human thymic MR1-restricted MAIT cells are innate 837 
pathogen-reactive effectors that adapt following thymic egress. Mucosal 838 
immunology 6, 35-44, doi:10.1038/mi.2012.45 (2013). 839 
13 Reantragoon, R. et al. Antigen-loaded MR1 tetramers define T cell 840 
receptor heterogeneity in mucosal-associated invariant T cells. The 841 
Journal of experimental medicine 210, 2305-2320, 842 
doi:10.1084/jem.20130958 (2013). 843 
 27 
14 Jiang, J. et al. MAIT Cell Function is Modulated by PD-1 Signaling in 844 
Patients with Active Tuberculosis. Am J Respir Crit Care Med, 845 
doi:10.1164/rccm.201401-0106OC (2014). 846 
15 Gold, M. C. & Lewinsohn, D. M. Co-dependents: MR1-restricted MAIT 847 
cells and their antimicrobial function. Nature reviews. Microbiology, 848 
doi:10.1038/nrmicro2918 (2012). 849 
16 Gold, M. C. et al. MR1-restricted MAIT cells display ligand discrimination 850 
and pathogen selectivity through distinct T cell receptor usage. J Exp 851 
Med, doi:10.1084/jem.20140507 (2014). 852 
17 Sharma, P. K. et al. High Expression of CD26 Accurately Identifies 853 
Human Bacterial-Reactive MR1-restricted MAIT cells. Immunology, 854 
doi:10.1111/imm.12461 (2015). 855 
18 Gold, M. C. et al. Human mucosal associated invariant T cells detect 856 
bacterially infected cells. PLoS biology 8, e1000407, 857 
doi:10.1371/journal.pbio.1000407 (2010). 858 
19 Nunes-Alves, C. et al. Human and Murine Clonal CD8+ T Cell Expansions 859 
Arise during Tuberculosis Because of TCR Selection. PLoS pathogens 11, 860 
e1004849, doi:10.1371/journal.ppat.1004849 (2015). 861 
20 Carlson, C. S. et al. Using synthetic templates to design an unbiased 862 
multiplex PCR assay. Nature communications 4, 2680, 863 
doi:10.1038/ncomms3680 (2013). 864 
21 Greenaway, H. Y. et al. NKT and MAIT invariant TCRalpha sequences can 865 
be produced efficiently by VJ gene recombination. Immunobiology, 866 
doi:10.1016/j.imbio.2012.04.003 (2012). 867 
22 Shen, W.-J. W., Hau-San; Xiao, Quan-Wu; Guo, Xin; Smale, Stephen. 868 
Towards a Mathematical Foundation of Immunology and Amino Acid 869 
Chains. eprint arXiv:1205.6031 (2012). 870 
23 Greenaway, H. Y. et al. NKT and MAIT invariant TCRalpha sequences can 871 
be produced efficiently by VJ gene recombination. Immunobiology 218, 872 
213-224, doi:10.1016/j.imbio.2012.04.003 (2013). 873 
24 McWilliam, H. E. et al. The intracellular pathway for the presentation of 874 
vitamin B-related antigens by the antigen-presenting molecule MR1. 875 
Nature immunology 17, 531-537, doi:10.1038/ni.3416 (2016). 876 
25 Dusseaux, M. et al. Human MAIT cells are xenobiotic-resistant, tissue-877 
targeted, CD161hi IL-17-secreting T cells. Blood 117, 1250-1259, 878 
doi:10.1182/blood-2010-08-303339 (2011). 879 
26 Gibbs, A. et al. MAIT cells reside in the female genital mucosa and are 880 
biased towards IL-17 and IL-22 production in response to bacterial 881 
stimulation. Mucosal immunology, doi:10.1038/mi.2016.30 (2016). 882 
27 Sharma, P. K. et al. High expression of CD26 accurately identifies human 883 
bacteria-reactive MR1-restricted MAIT cells. Immunology, 884 
doi:10.1111/imm.12461 (2015). 885 
28 Tobin, D. M. et al. Host genotype-specific therapies can optimize the 886 
inflammatory response to mycobacterial infections. Cell 148, 434-446, 887 
doi:10.1016/j.cell.2011.12.023 (2012). 888 
 28 
29 Leeansyah, E. et al. Activation, exhaustion and persistent decline of the 889 
anti-microbial MR1-restricted MAIT cell population in chronic HIV-1 890 
infection. Blood, doi:10.1182/blood-2012-07-445429 (2012). 891 
30 Eberhard, J. M. et al. CD161+ MAIT cells are severely reduced in 892 
peripheral blood and lymph nodes of HIV-infected individuals 893 
independently of disease progression. PloS one 9, e111323, 894 
doi:10.1371/journal.pone.0111323 (2014). 895 
31 Shane, H. L. & Klonowski, K. D. Every breath you take: the impact of 896 
environment on resident memory CD8 T cells in the lung. Frontiers in 897 
immunology 5, 320, doi:10.3389/fimmu.2014.00320 (2014). 898 
32 Van Rhijn, I. et al. A conserved human T cell population targets 899 
mycobacterial antigens presented by CD1b. Nature immunology 14, 900 
706-713, doi:10.1038/ni.2630 (2013). 901 
33 Laugel, B. et al. Engineering of Isogenic Cells Deficient for MR1 with a 902 
CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen 903 
Processing and Presentation to Human MR1-Restricted T Cells. J 904 
Immunol 197, 971-982, doi:10.4049/jimmunol.1501402 (2016). 905 
34 Riddell, S. R., Rabin, M., Geballe, A. P., Britt, W. J. & Greenberg, P. D. Class 906 
I MHC-restricted cytotoxic T lymphocyte recognition of cells infected 907 
with human cytomegalovirus does not require endogenous viral gene 908 
expression. J Immunol 146, 2795-2804 (1991). 909 
35 Reantragoon, R. et al. Structural insight into MR1-mediated recognition 910 
of the mucosal associated invariant T cell receptor. The Journal of 911 
experimental medicine 209, 761-774, doi:10.1084/jem.20112095 912 
(2012). 913 
36 Harriff, M. J. et al. MR1 displays the microbial metabolome driving 914 
selective MR1-restricted T cell receptor usage. Science immunology 3, 915 
doi:10.1126/sciimmunol.aao2556 (2018). 916 
37 Sakala, I. G. et al. Functional Heterogeneity and Antimycobacterial 917 
Effects of Mouse Mucosal-Associated Invariant T Cells Specific for 918 
Riboflavin Metabolites. J Immunol, doi:10.4049/jimmunol.1402545 919 
(2015). 920 
38 Chen, Z. et al. Mucosal-associated invariant T-cell activation and 921 
accumulation after in vivo infection depends on microbial riboflavin 922 
synthesis and co-stimulatory signals. Mucosal immunology 10, 58-68, 923 
doi:10.1038/mi.2016.39 (2017). 924 
39 Howson, L. J. et al. MAIT cell clonal expansion and TCR repertoire 925 
shaping in human volunteers challenged with Salmonella Paratyphi A. 926 
Nature communications 9, 253, doi:10.1038/s41467-017-02540-x 927 
(2018). 928 
40 Mitchell, J. E. et al. Prospective monitoring reveals dynamic levels of T 929 
cell immunity to Mycobacterium tuberculosis in HIV infected 930 
individuals. PloS one 7, e37920, doi:10.1371/journal.pone.0037920 931 
(2012). 932 
 29 
41 Lepore, M. et al. Parallel T-cell cloning and deep sequencing of human 933 
MAIT cells reveal stable oligoclonal TCRbeta repertoire. Nature 934 
communications 5, 3866, doi:10.1038/ncomms4866 (2014). 935 
42 Quigley, M. F., Almeida, J. R., Price, D. A. & Douek, D. C. Unbiased 936 
molecular analysis of T cell receptor expression using template-switch 937 
anchored RT-PCR. Current protocols in immunology / edited by John E. 938 
Coligan ... [et al.] Chapter 10, Unit10 33, 939 
doi:10.1002/0471142735.im1033s94 (2011). 940 
43 Price, D. A. et al. Avidity for antigen shapes clonal dominance in CD8+ T 941 
cell populations specific for persistent DNA viruses. J Exp Med 202, 942 
1349-1361, doi:10.1084/jem.20051357 (2005). 943 
 944 
 945 
  946 
 30 
Table 1. TCRα/β sequences and MAIT Match scores for six MAIT cell clones and two control clones derived 
from bronchoalveolar fluid from a patient with tuberculosis. 
 TCR sequencing  TCR sequencing 
Clone TRAV CDR3 TRAJ 
MAIT 
Match 
score  TRBV CDR3 TRBJ 
MAIT cell clones       
D0033-A1 1-2 CAALDSNYQLIW 33 1.00  4-3 CASSQDMVSITDTQY 2-3 
D0033-A2 1-2 CAVTDSNYQLIW 33 1.00  3-1 CASSQAETELNTGELF 2-2 
D0033-A3 1-2 CVTMDSNYQLIW 33 0.98  6-1 CASSEAGGGYNEQF 2-1 
D0033-A6 1-2 CAVVDSNYQLIW 33 1.00  4-2 CASSHSSGTGGNEQF 2-1 
D0033-A8 1-2 CVTMDSNYQLIW 33 0.98  6-1 CASSEAGGGYNEQF 2-1 
D0033-
A10 1-2 CAVTDSNYQLIW 33 1.00  3-1 CASSSGLEVTGELF 2-2 
Control T cell clones       
D0033-D7 20 CAARFSDGQKLL 16 0.92  7-9 CASSEGTGVEWDGYT 1-2 
D0033-E7 39 CAVPGGGADGLT 45 0.85  2 CASVASGVRDTQY 2-3 
 947 
 948 
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Table 2. Comparison of MR1/5-OPRU tetramer staining and usage of MAIT cell-consistent CDR3 sequences within TRAV1-
2+ CD8+ T cells in the bronchoalveolar (BAL) and peripheral blood (PBMC) compartments from two patients with active TB. 
Participant ID Compartment 
% MAIT cell-consistent 
CDR3  
% MR1/5-OPRU 
tetramer-positive  
% MAIT cell-consistent 
CDR3 of MR1/5-OPRU 
tetramer-positive 
% MAIT cell-consistent 
CDR3 of MR1/5-OPRU 
tetramer-negative 
1020 BAL 40.7 33.7 93.9 13.7 
1020 PBMC 5.4 3.1 89.2 2.7 
0091  BAL 28.5 5.1 100.0 24.7 
0091 PBMC 18.6 6.3 71.4 15.1 
  950 
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Table 3. TCRα/β sequences and MAIT Match scores for four T cell clones derived from bronchoalveolar cells. 
 TCR sequencing  TCR sequencing 
Clone TRAV CDR3 TRAJ 
MAIT 
Match 
score   TRBV CDR3 TRBJ 
D1004-B3 1-2 CAVTDSNYQLIW 33 1.00  6-5 CASSYEGGGQPQHF 1-5 
D1004-E1 1-2 CAALDSNYQLIW 33 1.00  6-4 CASSDGEGQPQHF 1-5 
D1004-E5 1-2 CAAMDSNYQLIW 33 1.00  30-1 CAWSHSDRDLNEQYF 2-7 
D1004-H3 1-2 CAAMDSNYQLIW 33 1.00  3 CASSQASGGEETQYF 2-5 
 951 
